Natco Pharma

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active [pharmaceutical ingredients] and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices.

History

Natco Pharma was founded in 1981 by V C Nannapaneni
In 1983, operations commenced at manufacturing facility at Nagarjunasagar, Telangana
In 1986, the company's chemical division started at Mekaguda, Telangana
In 2008, Natco Pharma filed its first paragraph IV filing in the US with the USFDA,
In 2012, Natco Pharma obtained compulsory license to produce a cheaper and generic version of Bayer's anti-cancer medication Nexavar.
In the United States, it launched influenza medication Tamiflu with marketing partner Alvogen, multiple sclerosis treatment drug glatiramer acetate in partnership with Mylan, and hepatitis C drugs under a licensing agreement with Gilead Sciences.
In 2016, Natco Pharma launched the first Tamiflu capsule in the US market.
In 2017, Natco Pharma launched a generic version of blood cancer drug Pomalidomide in the United States.
In 2019, Natco Pharma initiated work on green-field manufacturing facilities for producing niche agrichemical products in Nellore district, Andhra Pradesh.
In 2022, its Crop Health Sciences division launched chlorantraniliprole based products.
Natco launched the first generic version of Multiple myeloma drug Revlimid in the US market